XML 38 R23.htm IDEA: XBRL DOCUMENT v3.5.0.2
Equity awards (Tables)
 6 Months Ended
Jun. 30, 2016
Equity awards [Abstract]  
Option Award Activity
The following is a summary of stock option award activity under the Emergent Plans:

  
2006 Plan
  
2004 Plan
    
  
Number of Shares
  
Weighted-Average Exercise Price
  
Number of Shares
  
Weighted-Average Exercise Price
  
Aggregate Intrinsic Value
 
Outstanding at December 31, 2015
  
2,964,237
  
$
22.73
   
29,699
  
$
10.28
  
$
52,119,607
 
Granted
  
391,158
  
$
33.83
   
-
  
$
-
     
Exercised
  
(700,605
)
 
$
19.32
   
(29,699
)
 
$
10.28
     
Forfeited
  
(24,467
)
 
$
26.76
   
-
  
$
-
     
Outstanding at June 30, 2016
  
2,630,323
  
$
25.25
   
-
  
$
-
  
$
10,318,273
 
Exercisable at June 30, 2016
  
1,479,516
  
$
21.55
   
-
  
$
-
  
$
9,850,228
 
Restricted Stock Units Activity
The following is a summary of restricted stock unit award activity under the 2006 Plan:

  
Number of Shares
  
Weighted-Average Grant Price
  
Aggregate Intrinsic Value
 
Outstanding at December 31, 2015
  
889,004
  
$
26.86
  
$
35,569,048
 
Granted
  
470,911
  
$
34.53
     
Vested
  
(404,585
)
 
$
24.77
     
Forfeited
  
(26,103
)
 
$
30.95
     
Outstanding at June 30, 2016
  
929,227
  
$
31.53
  
$
26,129,863
 

On May 19, 2016, at the Company's annual meeting, the shareholders approved the issuance of 3.8 million shares under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, none of which have been issued. In addition, the shareholders approved an increase in the number of authorized shares of common stock to 200 million shares.

On July 14, 2016, the Company's board of directors authorized management to repurchase, from time to time, up to an aggregate of $50 million of the Company's common stock under a board-approved share repurchase program. The timing, amount, and price of any repurchases will be made pursuant to one or more 10b5-1 plans. The term of the board authorization of the repurchase program is until December 31, 2017. The plan will permit shares to be repurchased when the Company might otherwise be precluded from doing so under insider trading laws. The repurchase program may be suspended or discontinued at any time. Any repurchased shares will be available for use in connection with Emergent's stock plans and for other corporate purposes.

In March 2016, the FASB issued ASU 2016-09, Compensation - Stock Compensation (Topic 718). ASU 2016-09 simplifies several aspects of the accounting for share-based payment award transactions, including: (1) the income tax consequences, (2) classification of awards as either equity or liabilities, and (3) classification on the statement of cash flows. ASU 2016-09 is effective for the annual reporting period beginning after December 15, 2016, including interim periods within that reporting period, with early adoption permitted. The Compnay is currently evaluating the impact that the adoption of ASU 2016-09 will have on the consolidated financial statements and related disclosures.